Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer.

about

Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer.

Item

http://www.wikidata.org/entity/Q36085503

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@ast

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@en

type

Item

label

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@ast

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@en

prefLabel

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@ast

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@en

P1476

Combined therapy with EGFR TKI ...... EGFR-T790M mutant lung cancer.

@en

P2093

Chaoyang Wang

http://www.w3.org/2001/XMLSchema#string

Chengde Wang

http://www.w3.org/2001/XMLSchema#string

Hui Tian

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yijun Tang

http://www.w3.org/2001/XMLSchema#string

P2860

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells.

Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.

Lung cancer in China: challenges and interventions.

Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells.

Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance

P304

2063-2066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282450429

http://www.w3.org/2001/XMLSchema#string

P698

26622796

http://www.w3.org/2001/XMLSchema#string

P932

4579844

http://www.w3.org/2001/XMLSchema#string